The HER2/neu (ErbB) oncogene family plays a significant role in the growth, development, and metastasis of several tumor types, including ovarian and breast cancer, and its early expression in BC is associated with a significantly increased risk of cancer recurrence post-treatment [120]. This evidence concerns the gene ERBB2 and neoplasm.